Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SBFMW
- Price
- 0.58
- Stock movement up
- +0.38 (187.95%)
- Company name
- Sunshine Biopharma Inc. Warrant
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- -
- Ent value
- -7.19M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -28.73%
- 1 year return
- 859.83%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
SBFMW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | -0.22 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -3.33 |
| FCF per share (TTM) | -10.97 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 32.96M |
| Gross profit (TTM) | 9.94M |
| Operating income (TTM) | -4.62M |
| Net income (TTM) | -4.23M |
| EPS (TTM) | -3.33 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 30.17% |
| Operating margin (TTM) | -14.03% |
| Profit margin (TTM) | -12.82% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.21M |
| Net receivables | 3.22M |
| Total current assets | 25.98M |
| Goodwill | 0.00 |
| Intangible assets | 2.94M |
| Property, plant and equipment | 1.13M |
| Total assets | 30.06M |
| Accounts payable | 4.16M |
| Short/Current long term debt | 556.55K |
| Total current liabilities | 4.53M |
| Total liabilities | 5.02M |
| Shareholder's equity | 25.04M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -11.81M |
| Capital expenditures (TTM) | 2.09M |
| Free cash flow (TTM) | -13.91M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -16.88% |
| Return on Assets | -14.06% |
| Return on Invested Capital | -16.80% |
| Cash Return on Invested Capital | -55.28% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.58 |
| Daily high | 0.58 |
| Daily low | 0.58 |
| Daily Volume | 0K |
| All-time high | 7.43 |
| 1y analyst estimate | - |
| Beta | -1.04 |
| EPS (TTM) | -3.33 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SBFMW | S&P500 | |
| Current price drop from All-time high | -92.25% | -12.89% |
| Highest price drop | -99.52% | -56.47% |
| Date of highest drop | 13 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -89.59% | -11.07% |
| Avg time to new high | 66 days | 12 days |
| Max time to new high | 620 days | 1805 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.
Employees
44
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner